Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
139 hedge funds and large institutions have $1.35B invested in Amicus Therapeutics in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 34 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 36
8.74% more ownership
Funds ownership: 102.34% → 111.08% (+8.7%)
6% more call options, than puts
Call options by funds: $11.3M | Put options by funds: $10.6M
5% less funds holding
Funds holding: 147 → 139 (-8)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 34
24% less capital invested
Capital invested by funds: $1.76B → $1.35B (-$416M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$35.5M |
| 2 |
D.E. Shaw & Co
New York
|
+$18.3M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$17.6M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$16.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$38.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$38.4M |
| 3 |
Millennium Management
New York
|
-$33.3M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$12.1M |
| 5 |
Axa
Paris,
France
|
-$8.09M |
FOLD Hedge Fund Activity: Q4 2015 in Review
139 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2015, worth a combined $1.35B — down 24% from $1.76B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of FOLD and 28 opened new positions — a net loss of 6 holders — while 36 trimmed existing stakes and 63 added.
The largest buyer was Fidelity Investments, adding an estimated $35.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $38.5M sold.
- 139 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2015, down from 147 in Q3 2015.
- Funds reported $1.35B of Amicus Therapeutics stock for Q4 2015, down 24% quarter-over-quarter.
- 28 funds opened new Amicus Therapeutics positions in Q4 2015 and 34 closed out, a net change of -6 holders.
- The largest Amicus Therapeutics buyer in Q4 2015 was Fidelity Investments, an estimated $35.5M added.
- The largest Amicus Therapeutics seller in Q4 2015 was Lord, Abbett & Co, an estimated $38.5M sold.
Based on aggregated 13F filings for Q4 2015.